Come up with a name for your new list and we'll add to it:
DCPrime raised a round of funding on September 20, 2010. Investors include
Thuja Capital Management.
DCPrime is a clinical stage company which develops novel cancer immunotherapies based on its DCOne platform technology. This platform combines antigen carrier properties with the immune-stimulatory pr…